Machine learning approaches to predict drug responses in cancer from multi-omics data

Cancer is a complex disease that involves genetic mutations and diverse tumour behaviour and characteristics. With its complexities, there comes major challenges when it comes to treating cancer such as requiring personalised treatment. Therefore, it is important for medical experts to have a det...

Full description

Saved in:
Bibliographic Details
Main Author: Muhammad Zaki Bin Mohammad Bakri
Other Authors: Jagath C Rajapakse
Format: Final Year Project
Language:English
Published: Nanyang Technological University 2023
Subjects:
Online Access:https://hdl.handle.net/10356/171943
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
Description
Summary:Cancer is a complex disease that involves genetic mutations and diverse tumour behaviour and characteristics. With its complexities, there comes major challenges when it comes to treating cancer such as requiring personalised treatment. Therefore, it is important for medical experts to have a detailed understanding of patients’ cancer cells to be able to administer medicinal efforts effectively. In this day and age there is an abundance of data which also includes the various omics data of cancer cells. With these omics data and integrating them together, medical experts can analyse the relationships between each omics and obtain new insights into each biological component during stages of cancer. This can help in understanding cancer cells as well as improving the personalised treatment of cancer. In this project, our end goal was to predict drug responses of cancer cell lines from multi-omics data. However, multi-omics data has high dimensions which makes it difficult for integration and analysis. Hence the approach we have taken to tackle this high dimensionality issue was by implementing a dimension reduction technique using Variational Autoencoders (VAE). Various integration techniques were also explored. Afterwards, a deep neural network predictor was built to predict drug responses of cancer cells. With this predictor, this will help in future drug and cancer research as well as improve current cancer treatment.